These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7714686)

  • 1. The prognostic significance of caffeine half-life in saliva in children with chronic liver disease.
    Baker A; Girling A; Worthington D; Ballantine N; Smith S; Tarlow M; Kelly D
    J Pediatr Gastroenterol Nutr; 1995 Feb; 20(2):196-201. PubMed ID: 7714686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine clearance in cirrhosis. The value of simplified determinations of liver metabolic capacity.
    Lewis FW; Rector WG
    J Hepatol; 1992 Mar; 14(2-3):157-62. PubMed ID: 1500679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at night.
    Wahlländer A; Mohr S; Paumgartner G
    J Hepatol; 1990 Mar; 10(2):129-37. PubMed ID: 2185297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases.
    el-Yazigi A; Shabib S; al-Rawithi S; Yusuf A; Legayada ES; al-Humidan A
    J Clin Pharmacol; 1999 Apr; 39(4):366-72. PubMed ID: 10197295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
    Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic dysfunction and cardiovascular abnormalities. Occurrence in infants, children, and young adults.
    Mace S; Borkat G; Liebman J
    Am J Dis Child; 1985 Jan; 139(1):60-5. PubMed ID: 3969985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
    Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
    Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.
    Scott NR; Stambuk D; Chakraborty J; Marks V; Morgan MY
    Br J Clin Pharmacol; 1989 Feb; 27(2):205-13. PubMed ID: 2713214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell transplantation for the treatment of liver diseases: A systematic review and meta-analysis.
    Liu Z; Li J; Li P; Bai M; Guo Y; Han M; Zhang F; Ahmed R; Jin S
    Turk J Gastroenterol; 2016 Nov; 27(6):499-508. PubMed ID: 27852540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid high-performance liquid chromatography assay for salivary and serum caffeine following an oral load. An indicator of liver function.
    Setchell KD; Welsh MB; Klooster MJ; Balistreri WF; Lim CK
    J Chromatogr; 1987 Jan; 385():267-74. PubMed ID: 3558581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
    Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
    Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lidocaine metabolite formation as a quantitative liver function test in children.
    Gremse DA; A-Kader HH; Schroeder TJ; Balistreri WF
    Hepatology; 1990 Sep; 12(3 Pt 1):565-9. PubMed ID: 2401461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of laboratory tests in liver disease.
    Tygstrup N
    Scand J Gastroenterol Suppl; 1973; 19():47-50. PubMed ID: 4123936
    [No Abstract]   [Full Text] [Related]  

  • 15. Parameters obtained by hepatobiliary scintigraphy have significant correlation with biochemical factors early after liver transplantation.
    Kansoul HA; Axelsson R; Yamamoto S; Savicheva I; Aspelin P; Ericzon BG; Gjertsen H
    Acta Radiol; 2007 Jul; 48(6):597-604. PubMed ID: 17611864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired elimination of caffeine in cirrhosis.
    Desmond PV; Patwardhan RV; Johnson RF; Schenker S
    Dig Dis Sci; 1980 Mar; 25(3):193-7. PubMed ID: 7371463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients].
    Chen YP; Hou JL; Dai L; Wang JL; Zhu YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2157-60. PubMed ID: 19114345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of azathioprine on hepatic reserve in chronic active liver disease.
    Rikkers L; Sherlock S
    Gut; 1975 Mar; 16(3):214-9. PubMed ID: 1123176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine intake, fasting plasma caffeine and caffeine clearance in patients with liver diseases.
    Marchesini G; Checchia GA; Grossi G; Lolli R; Bianchi GP; Zoli M; Pisi E
    Liver; 1988 Aug; 8(4):241-6. PubMed ID: 3419291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.